GC-MS based metabolite fingerprinting of serous ovarian carcinoma and benign ovarian tumor

被引:7
|
作者
Eroglu, Evren Caglar [1 ]
Gulec, Umran Kucukgoz [2 ]
Vardar, Mehmet Ali [2 ]
Paydas, Semra [3 ]
机构
[1] Alata Hort Res Inst, Mersin, Turkey
[2] Cukurova Univ, Med Fac, Dept Gynecol Oncol, Adana, Turkey
[3] Cukurova Univ, Med Fac, Dept Oncol, Adana, Turkey
关键词
metabolomics; biomarker; ovarian cancer; benign tumor; healthy control; GC-MS; OPLS-DA; BIOMARKER DISCOVERY; MASS-SPECTROMETRY; PROSTATE-CANCER; METABOLOMICS; DIAGNOSIS; URINE; SERUM; IDENTIFICATION; PLASMA;
D O I
10.1177/14690667221098520
中图分类号
O64 [物理化学(理论化学)、化学物理学]; O56 [分子物理学、原子物理学];
学科分类号
070203 ; 070304 ; 081704 ; 1406 ;
摘要
The aim of this study is to identify urinary metabolomic profile of benign and malign ovarian tumors patients. Samples were analyzed using gas chromatography-mass spectrometry (GC-MS) and metabolomic tools to define biomarkers that cause differentiation between groups. 7 metabolites were found to be different in patients with ovarian cancer (OC) and benign tumors (BT). R2Y and Q2 values were found to be 0.670 and 0.459, respectively. L-tyrosine, glycine, stearic acid, turanose and L-threonine metabolites were defined as prominent biomarkers. The sensitivity of the model was calculated as 90.72% and the specificity as 82.09%. In the pathway analysis, glutathione metabolism, aminoacyl-tRNA biosynthesis, glycine serine and threonine metabolic pathway, primary bile acid biosynthesis pathways were found to be important. According to the t-test, 29 metabolites were found to be significant in urine samples of OC patients and healthy controls (HC). R2Y and Q2 values were found to be 0.8170 and 0.749, respectively. These results showed that the model has high compatibility and predictive power. Benzoic acid, L-threonine, L-pyroglutamic acid, creatinine and 3,4-dihydroxyphenylacetic acid metabolites were determined as prominent biomarkers. The sensitivity of the model was calculated as 93.81% and the specificity as 98.59%. Glycine serine and threonine metabolic pathway, glutathione metabolism and aminoacyl-tRNA biosynthesis pathways were determined important in OC patients and HC. The R2Y, Q2, sensitivity and specificity values in the urine samples of BT patients and HC were found to be 0.869, 0.794, 91.75, 97.01% and 97.18%, respectively. L-threonine, L-pyroglutamic acid, benzoic acid, creatinine and pentadecanol metabolites were determined as prominent biomarkers. Valine, leucine and isoleucine biosynthesis and aminoacyl-tRNA biosynthesis were significant. In this study, thanks to the untargeted metabolomic approach and chemometric methods, every group was differentiated from the others and prominent biomarkers were determined.
引用
收藏
页码:12 / 24
页数:13
相关论文
共 50 条
  • [1] Discovery of metabolomic biomarkers for discriminating platinum-sensitive and platinum-resistant ovarian cancer by using GC-MS
    Eroglu, Evren C.
    Tunug, Sule
    Geckil, Omer Faruk
    Gulec, Umran Kucukgoz
    Vardar, Mehmet Ali
    Paydas, Semra
    EUROPEAN JOURNAL OF MASS SPECTROMETRY, 2021, 27 (06) : 235 - 248
  • [2] Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors
    Buas, Matthew F.
    Gu, Haiwei
    Djukovic, Danijel
    Zhu, Jiangjiang
    Drescher, Charles W.
    Urban, Nicole
    Raftery, Daniel
    Li, Christopher I.
    GYNECOLOGIC ONCOLOGY, 2016, 140 (01) : 138 - 144
  • [3] Comparative Metabolite Fingerprinting of Four Different Cinnamon Species Analyzed via UPLC-MS and GC-MS and Chemometric Tools
    Farag, Mohamed A.
    Kabbash, Eman M.
    Mediani, Ahmed
    Doll, Stefanie
    Esatbeyoglu, Tuba
    Afifi, Sherif M.
    MOLECULES, 2022, 27 (09):
  • [4] Use of chemical ionization for GC-MS metabolite profiling
    Warren, Charles R.
    METABOLOMICS, 2013, 9 (01) : S110 - S120
  • [5] Saturated fatty acids as possible important metabolites for epithelial ovarian cancer based on the free and esterified fatty acid profiles determined by GC-MS analysis
    Yin, Rui
    Yang, Tongshu
    Su, Hui
    Ying, Li
    Liu, Liyan
    Sun, Changhao
    CANCER BIOMARKERS, 2016, 17 (03) : 259 - 269
  • [6] Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study
    Struck-Lewicka, Wiktoria
    Kordalewska, Marta
    Bujak, Renata
    Mpanga, Arlette Yumba
    Markuszewski, Marcin
    Jacyna, Julia
    Matuszewski, Marcin
    Kaliszan, Roman
    Markuszewski, Michal J.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2015, 111 : 351 - 361
  • [7] Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
    Dey, Puja
    Nakayama, Kentaro
    Razia, Sultana
    Ishikawa, Masako
    Ishibashi, Tomoka
    Yamashita, Hitomi
    Kanno, Kosuke
    Sato, Seiya
    Kiyono, Tohru
    Kyo, Satoru
    CANCERS, 2022, 14 (06)
  • [8] Comparative metabolite profiling and fingerprinting of medicinal licorice roots using a multiplex approach of GC-MS, LC-MS and 1D NMR techniques
    Farag, Mohamed A.
    Porzel, Andrea
    Wessjohann, Ludger A.
    PHYTOCHEMISTRY, 2012, 76 : 60 - 72
  • [9] GC-MS Based Metabolite Profiling of Rice Koji Fermentation by Various Fungi
    Kim, Ah Jin
    Choi, Jung Nam
    Kim, Jiyoung
    Park, Sait Byul
    Yeo, Soo Hwan
    Choi, Ji Ho
    Lee, Choong Hwan
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2010, 74 (11) : 2267 - 2272
  • [10] GC-MS based metabolomics used for the identification of cancer volatile organic compounds as biomarkers
    Lubes, Giuseppe
    Goodarzi, Mohammad
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018, 147 : 313 - 322